论文信息 - A phase I trial of vertical inhibition of IGF signalling using cixutumumab, an anti-IGF-1R antibody, and selumetinib, an MEK 1/2 inhibitor, in advanced solid tumours - 字舞流文

A phase I trial of vertical inhibition of IGF signalling using cixutumumab, an anti-IGF-1R antibody, and selumetinib, an MEK 1/2 inhibitor, in advanced solid tumours

R. Donehower | L. Doyle | M. Rudek | B. Nelkin | D. Ball | D. Cosgrove | X. Ye | C. Womack | D. Laheru | N. Azad | G. Bigley | B. Wilky | S. Ahmed | H. Chen